These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38123948)

  • 1. The Current Status and Use of Microphysiological Systems by the Pharmaceutical Industry: The International Consortium for Innovation and Quality Microphysiological Systems Affiliate Survey and Commentary.
    Baker TK; Van Vleet TR; Mahalingaiah PK; Grandhi TSP; Evers R; Ekert J; Gosset JR; Chacko SA; Kopec AK
    Drug Metab Dispos; 2024 Feb; 52(3):198-209. PubMed ID: 38123948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to a manuscript series on the characterization and use of microphysiological systems (MPS) in pharmaceutical safety and ADME applications.
    Fabre K; Berridge B; Proctor WR; Ralston S; Will Y; Baran SW; Yoder G; Van Vleet TR
    Lab Chip; 2020 Mar; 20(6):1049-1057. PubMed ID: 32073020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perspectives on the evaluation and adoption of complex in vitro models in drug development: Workshop with the FDA and the pharmaceutical industry (IQ MPS Affiliate).
    Baran SW; Brown PC; Baudy AR; Fitzpatrick SC; Frantz C; Fullerton A; Gan J; Hardwick RN; Hillgren KM; Kopec AK; Liras JL; Mendrick DL; Nagao R; Proctor WR; Ramsden D; Ribeiro AJS; Stresser D; Sung KE; Sura R; Tetsuka K; Tomlinson L; Van Vleet T; Wagoner MP; Wang Q; Arslan SY; Yoder G; Ekert JE
    ALTEX; 2022; 39(2):297–314. PubMed ID: 35064273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug Development.
    Tomlinson L; Ramsden D; Leite SB; Beken S; Bonzo JA; Brown P; Candarlioglu PL; Chan TS; Chen E; Choi CK; David R; Delrue N; Devine PJ; Ford K; Garcia MI; Gosset JR; Hewitt P; Homan K; Irrechukwu O; Kopec AK; Liras JL; Mandlekar S; Raczynski A; Sadrieh N; Sakatis MZ; Siegel J; Sung K; Sunyovszki I; Van Vleet TR; Ekert JE; Hardwick RN
    Adv Biol (Weinh); 2024 Aug; 8(8):e2300131. PubMed ID: 37814378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of microphysiological systems for nonclinical evaluation of cell therapies.
    Candarlioglu PL; Delsing L; Gauthier L; Lewis L; Papadopoulos G; Freag M; Chan TS; Homan KA; Fellows MD; Pointon A; Kojala K
    ALTEX; 2024; 41(3):469-484. PubMed ID: 38746991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microphysiological systems in early stage drug development: Perspectives on current applications and future impact.
    Kopec AK; Yokokawa R; Khan N; Horii I; Finley JE; Bono CP; Donovan C; Roy J; Harney J; Burdick AD; Jessen B; Lu S; Collinge M; Sadeghian RB; Derzi M; Tomlinson L; Burkhardt JE
    J Toxicol Sci; 2021; 46(3):99-114. PubMed ID: 33642521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toward Regulatory Acceptance of MPS-Cardiac Safety Assessment as an Example].
    Yamazaki D
    Yakugaku Zasshi; 2023; 143(1):55-63. PubMed ID: 36596540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of Microphysiological Systems (MPSs) Based on Microfluidic Technology for Drug Discovery in Japan].
    Kimura H
    Yakugaku Zasshi; 2023; 143(1):39-44. PubMed ID: 36596538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development.
    Marx U; Akabane T; Andersson TB; Baker E; Beilmann M; Beken S; Brendler-Schwaab S; Cirit M; David R; Dehne EM; Durieux I; Ewart L; Fitzpatrick SC; Frey O; Fuchs F; Griffith LG; Hamilton GA; Hartung T; Hoeng J; Hogberg H; Hughes DJ; Ingber DE; Iskandar A; Kanamori T; Kojima H; Kuehnl J; Leist M; Li B; Loskill P; Mendrick DL; Neumann T; Pallocca G; Rusyn I; Smirnova L; Steger-Hartmann T; Tagle DA; Tonevitsky A; Tsyb S; Trapecar M; Van de Water B; Van den Eijnden-van Raaij J; Vulto P; Watanabe K; Wolf A; Zhou X; Roth A
    ALTEX; 2020; 37(3):365-394. PubMed ID: 32113184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microphysiological lung models to evaluate the safety of new pharmaceutical modalities: a biopharmaceutical perspective.
    Ainslie GR; Davis M; Ewart L; Lieberman LA; Rowlands DJ; Thorley AJ; Yoder G; Ryan AM
    Lab Chip; 2019 Sep; 19(19):3152-3161. PubMed ID: 31469131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharma challenges to adoption of microphysiological system in drug research and development, especially safety assessment].
    Naraoka H
    Nihon Yakurigaku Zasshi; 2023; 158(2):187-192. PubMed ID: 36858504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microphysiological Systems: Stakeholder Challenges to Adoption in Drug Development.
    Hargrove-Grimes P; Low LA; Tagle DA
    Cells Tissues Organs; 2022; 211(3):269-281. PubMed ID: 34380142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives.
    Bolleddula J; Brady K; Bruin G; Lee A; Martin JA; Walles M; Xu K; Yang TY; Zhu X; Yu H
    Drug Metab Dispos; 2022 Jun; 50(6):837-845. PubMed ID: 35149541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges.
    Irrechukwu O; Yeager R; David R; Ekert J; Saravanakumar A; Choi CK
    ALTEX; 2023; 40(3):485-518. PubMed ID: 36648096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microphysiological systems for ADME-related applications: current status and recommendations for system development and characterization.
    Fowler S; Chen WLK; Duignan DB; Gupta A; Hariparsad N; Kenny JR; Lai WG; Liras J; Phillips JA; Gan J
    Lab Chip; 2020 Feb; 20(3):446-467. PubMed ID: 31932816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Navigating tissue chips from development to dissemination: A pharmaceutical industry perspective.
    Ewart L; Fabre K; Chakilam A; Dragan Y; Duignan DB; Eswaraka J; Gan J; Guzzie-Peck P; Otieno M; Jeong CG; Keller DA; de Morais SM; Phillips JA; Proctor W; Sura R; Van Vleet T; Watson D; Will Y; Tagle D; Berridge B
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1579-1585. PubMed ID: 28622731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.
    Ewart L; Dehne EM; Fabre K; Gibbs S; Hickman J; Hornberg E; Ingelman-Sundberg M; Jang KJ; Jones DR; Lauschke VM; Marx U; Mettetal JT; Pointon A; Williams D; Zimmermann WH; Newham P
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():65-82. PubMed ID: 29029591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in developing microphysiological systems for biological product assessment.
    Mansouri M; Lam J; Sung KE
    Lab Chip; 2024 Feb; 24(5):1293-1306. PubMed ID: 38230512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.